is being used in the remaining roughly 450 000 UK Biobank participants. The UK Biobank array shares more than 95% of its content with the UK BiLEVE array. When genotyping of all UK Biobank participants is complete, UK Biobank will provide a unique resource for genome-wide studies of quantitative traits, nested case-control studies, and studies in which longitudinal outcomes can be studied.
